CBS 2019
CBSMD教育中心
中 文

Percutaneous LAA Occlusion

Abstract

Recommended Article

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation: A Cohort Study Impact of left atrial appendage closure on circulating microvesicles levels: The MICROPLUG study Early Rhythm-Control Therapy in Patients with Atrial Fibrillation Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography​: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes

Clinical Trial2021 Apr 6;143(14):1377-1390.

JOURNAL: Article Link

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial

DL Packer, JP Piccini, CABANA Investigators et al. Keywords: AF; ablation versus drug therapy; outcome; RCT

Full Text PDF